|
Atomistry » Magnesium » PDB 3fps-3fzi » 3frg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Magnesium » PDB 3fps-3fzi » 3frg » |
Magnesium in PDB 3frg: Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline InhibitorEnzymatic activity of Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor
All present enzymatic activity of Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor:
3.1.4.17; Protein crystallography data
The structure of Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor, PDB code: 3frg
was solved by
D.O.Somers,
M.Neu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 3frg:
The structure of Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor
(pdb code 3frg). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor, PDB code: 3frg: Magnesium binding site 1 out of 1 in 3frgGo back to Magnesium Binding Sites List in 3frg
Magnesium binding site 1 out
of 1 in the Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor
Mono view Stereo pair view
Reference:
C.J.Lunniss,
A.W.Cooper,
C.D.Eldred,
M.Kranz,
M.Lindvall,
F.S.Lucas,
M.Neu,
A.G.Preston,
L.E.Ranshaw,
A.J.Redgrave,
J.Ed Robinson,
T.J.Shipley,
Y.E.Solanke,
D.O.Somers,
J.O.Wiseman.
Quinolines As A Novel Structural Class of Potent and Selective PDE4 Inhibitors: Optimisation For Oral Administration. Bioorg.Med.Chem.Lett. V. 19 1380 2009.
Page generated: Wed Aug 14 13:52:44 2024
ISSN: ISSN 0960-894X PubMed: 19195882 DOI: 10.1016/J.BMCL.2009.01.045 |
Last articlesMg in 4Y52Mg in 4Y30 Mg in 4Y2V Mg in 4Y2X Mg in 4Y2Y Mg in 4Y2U Mg in 4Y2T Mg in 4Y2Q Mg in 4Y2R Mg in 4Y2S |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |